Global, randomized Phase 2 study to evaluate the addition of givastomig, a CLDN18.2 x 4-1BB bispecific antibody (8 mg/kg and 12 mg/kg) to ...
Chief Executive Officer Craig Parker used a discussion at a 2026 investor summit to outline the company’s focus on Wnt pathway biology and antibody engineering, with an emphasis on retinal vascular ...
Ocular Therapeutix's current wet AMD treatment is dominated by anti-VEGF drugs, with EYLEA holding a 63% global market share in 2024. Read why OCUL stock is a sell.
Researchers at NYU Langone Health and its Perlmutter Cancer Center have discovered that a gene-regulating molecule called ...
Eylea was under pressure in 2025. Sales of Eylea plunged 42% in the United States to $2.7 billion, impacted by lower sales ...
A molecule that helps regulate gene activity has also been shown to drive skin cancer growth and tumors' ability to evade ...
A molecule that helps regulate gene activity has also been shown to drive skin cancer growth and tumors' ability to evade ...
The Brighterside of News on MSN
New research links the heart to the brain, nerves, and immune defenses
Arteries can narrow with fatty buildup. Blood struggles to move. Oxygen drops. A heart attack can follow, and it remains the world’s top killer. Researchers at the University of California San Diego ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results